Liyanage P. Perera

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 686 citations · Full text

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

Thomas A. Waldmann, Enrico Lugli, Mario Roederer et al. · Blood · 2011 · 191 citations · Full text

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

SangKon Oh, Jay A. Berzofsky, Donald S. Burke et al. · Proceedings of the National Academy of Sciences · 2003 · 187 citations · Full text

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants

James E. Samuel, Liyanage P. Perera, Sheila M. Ward et al. · Infection and Immunity · 1990 · 161 citations · Full text

Toxinology, Laboratory Immunology, Immunology +21

IL-15 as a mediator of CD4 ⁺ help for CD8 ⁺ T cell longevity and avoidance of TRAIL-mediated apoptosis

SangKon Oh, Liyanage P. Perera, Masaki Terabe et al. · Proceedings of the National Academy of Sciences · 2008 · 144 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +19